Skip to main content
SpringerLink
Log in
Book cover

Esterases, Lipases, and Phospholipases pp 169–178Cite as

LCAT: From Structure to Clinical Significance

  • Chapter

  • 100 Accesses

Part of the book series: NATO ASI Series ((NSSA,volume 266))

Abstract

Lecithin: cholesterol acyltransferase (LCAT; EC 2.3.1.43) is a plasma glycoprotein enzyme of the serine esterase type which is synthesized and secreted by hepatocytes and has a key role in the metabolism of cholesterol especially in reverse cholesterol transport (Efflux) from the peripheral tissues to the liver [1].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Glomset J.A. and Norum K.R. The metabolic role of lecithin: cholesterol acyltransferase. Adv. Lipid Res., 2, 1973, 1–65.

    Google Scholar 

  2. Hill J.S., Karmin O., Wang X., Paranjape S., Dimitrijevich D., Lacko A.G. and Pritchard P.H. Expression and characterization of recombinant lecithin: cholesterol acyl transferase. J. Lipid Res., 34, 1993, 1245–1251.

    PubMed  CAS  Google Scholar 

  3. Fielding C.J. and Collet X. Phopholipase activity of lecithin: cholesterol acyltransferase. in: Methods in enzymology, Acad. Press., 197, 1991, 426–433.

    Google Scholar 

  4. Subbaiah P.V., Liu M., Bolan P.J. and Paltauf F. Altered positional specificity of human plasma lecithin: cholesterol acyltransferase in the presence of sn-2 arachidonoryl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters. Biochim. Biophys. Acta, 1128, 1992, 83–92.

    Article  PubMed  CAS  Google Scholar 

  5. Parks J.S., Thuren T.Y. and Schmitt J.D. Inhibition of lecithin: cholesterol acyl acyltransferase activity by synthetic phosphatidylcholine species containing eicosapentaenoic acid or docosahexaenoic acid in the sn-2 position. J. Lipid Res., 33, 1992, 879–887.

    PubMed  CAS  Google Scholar 

  6. catalyzes transacylation of intact cholesteryl esters. J. Biol. Chem., 265, 1990, 2665–2670.

    Google Scholar 

  7. in Fish Eye Disease. Acta Med. Scand., 218, 1985, 189–196.

    Google Scholar 

  8. Brown M.L., Hesler C. and Tall R. Plasma enzymes and transfer proteins in cholesterol metabolism. Curr. Opinion Lipidol., 1, 1990, 122–127.

    Article  Google Scholar 

  9. Francone O.L., Gurakar A. and Fielding C. Distribution and functions of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J. Biol. Chem., 264, 1989, 7066–7072.

    PubMed  CAS  Google Scholar 

  10. Norum K.R. and Gjone E. Familial plasma lecithin: cholesterol acyltransferase deficiency. Biochemical study of a new inborn error of metabolism. Scand. J. Clin. Lab. Invest., 20, 1967, 231–243.

    Google Scholar 

  11. Carlson L.A. and Philipson B. Fish-Eye Disease: A new familial condition with massive corneal opacities and dyslipoproteinemia. Lancet, 2, 1979, 922–924.

    PubMed  CAS  Google Scholar 

  12. Frolich J., Hoag G., Mc Leod R., Hayden M., Godin D.V., Wadsworth L.D., Critchley J.D. and Pritchard P.N. Hypoalphalipoproteinemia resembling Fish Eye Disease. Acta Med. Scand., 221, 1987, 291–298.

    Article  Google Scholar 

  13. Assmann G., Von Eckardstein A. and Funke H. Lecithin: cholesterol acyltransferase and Fish Eye Disease. Curr. Opinion Lipid., 2, 1991, 110–117.

    Article  CAS  Google Scholar 

  14. Assmann G., Schmitz A., Funke H. and Von Eckardstein A. Apolipoprotein A-I and HDL deficiency. Curr. Opinion Lipid., 1, 1990, 110–115.

    Article  Google Scholar 

  15. Matsuzawa Y., Yamashita S., Kameda K., Kubo M., Tarin S and Hara I. Marked hyper-HDL2-cholesterolemia associated with premature corneal opacity. Atherosclerosis, 53, 1984, 207–212.

    Article  PubMed  CAS  Google Scholar 

  16. Mc Lean J., Fielding C., Drayna D., Dieplinger H., Baer B., Kohr W., Heuzel W. and Lawn R. Cloning and expression of human lecithin: cholesterol acyltransferase cDNA. Proc. Nati. Acad. Sci. USA, 83, 1986, 2335–2339.

    Article  CAS  Google Scholar 

  17. Chung K.S., Jahnani M., Hara S. and Lacko A.B. Human plasma LCAT amino acid sequence. Can. J. Biochem. Cell. Biol., 61, 1983, 875–881.

    Google Scholar 

  18. Teisberg P. and Gjone E. A probable linkage of LCAT in man to the alpha haptoglobine locus on chromosome 16. Nature, 249, 1974, 550–551.

    Article  PubMed  CAS  Google Scholar 

  19. Azoulay M., Henry I., Tata F., Weil D., Grzeschik K.H., Mc Intyre N., Williamson R., Humphries S.E. and Juniere C. The structural gene for human lecithin: cholesterol acyltransferase maps to 16 q 22. Cytogenet. Cell. Genet., 40, 1985, 573.

    Google Scholar 

  20. Meroni G., Malgaretti N., Pontoglio M., Ottolenghi S. and Tarannelli R. Functional analysis of the human LCAT gene promoter. B.B.R.C., 180, 1991, 1469–1475.

    CAS  Google Scholar 

  21. Yang C.Y., Manaogian D., Pao Q., Fee F.S., Knapp R.D., Gotta A.M. and Pownall H.J. Lecithin: cholesterol acyltransferase: functionnal regions and a structural model of the enzyme. J. Biochem., 262, 1987, 3086–3091.

    CAS  Google Scholar 

  22. Jauhiainen M., Stevenson K.J. and Dolphin P.J. Human lecithin: cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site. J. Biol. Chem., 263, 1988, 6525–6533.

    PubMed  CAS  Google Scholar 

  23. Francone O.I.. and Fielding C.J. Structure–Function relationships in human lecithin: cholesterol acyltransferase site–directed mutagenesis at serine residues 181 and 216. Biochemistry, 30, 1991, 10074–10077.

    Article  PubMed  CAS  Google Scholar 

  24. Francone O.L. and Fielding C.J. Effects of site -directed mutagenesis at residues of cysteine-31 and cysteine-184 on lecithin = cholesterol acyltransferase activity. Proc. Natl. Acad. Sci. USA, 88, 1991, 1716–1720.

    Article  PubMed  CAS  Google Scholar 

  25. Jonas A. Lecithin: cholesterol acyltransferase in the metabolism of high density lipoproteins. Biochim. Biophys. Acta, 1084, 1991, 205–220.

    Article  PubMed  CAS  Google Scholar 

  26. Subbaiah P.V. Lysolecithin acyltransferase of human plasma: assay and characterization of enzyme activity. in: Methods in Enzymology, Acad. Press, 129, 1986, 790–797.

    Google Scholar 

  27. Parthasarathy S. and Barnett J. Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apolipoprotein B-100. Proc. Natl. Acad. Sci. USA, 87, 1990, 9741–9745.

    Article  PubMed  CAS  Google Scholar 

  28. Collet X. and Fielding C.J. Effects of inhibitors of N-linked oligo saccharide processing on the secretion, stability, an activity of LCAT. Biochemistry, 30, 1991, 3228–3234.

    Article  PubMed  CAS  Google Scholar 

  29. Francone O.L., Evangelista L. and Fielding C.J. Lecithin-cholesterol acyltransferase: effects of mutagenesis at N-linket oligo saccharide attachment sites on acyl acceptor specificity. Biochim. Biophys. Acta, 1166, 1993, 301–304.

    Article  PubMed  CAS  Google Scholar 

  30. Anantharamaiah G.M., Venkatachalapathi Y.V., Brouillette C.G. and Segrest J.P. Use of synthetic peptide analogues to localize lecithin: cholesterol acyl transferase activating domain in apolipoprotein A-I. Arteriosclerosis, 10, 1990, 95–105.

    Article  PubMed  CAS  Google Scholar 

  31. Minnich A., Collet X., Roghani A., Cladaras C., Hamilton R.L., Fielding C. and Zannis V.I. Site directed mutagenesis and structure–function analysis of the human apo A-1. Relation between LCAT activation and lipid binding. J. Biol. Chem., 267, 1992, 16553–16560.

    PubMed  CAS  Google Scholar 

  32. Banka C.L., Bonnet D.J., Black A.S., Smith R.S. and Curtiss L.K. Localization of an apolipoprotein A-I epitope critical for activation of LCAT. J. Biol. Chem., 266, 1991, 23886–23892.

    CAS  Google Scholar 

  33. Wong L., Curtiss L.K., Huang J., Mann C.J., Maldonado B. and Roheim P.S. Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate LCAT. J. Clin. Invest., 90, 1992, 2370, 2375.

    Google Scholar 

  34. Calvo C., Ulloa N., Del Pozo R and Verdugo C. Decreased activation of LCAT by glucated apolipoprotein A-I. Eur. J. Clin. Chem. Clin. Biochem., 31, 1993, 217–220.

    CAS  Google Scholar 

  35. Taranelli R., Pontoglio M., Candiani G., Ottolenghi S., Dieplinger H., Catapeno A., Albers J., Vergani C. and Mc Lean J. Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele. Hum. Genet., 85, 1990, 195–199.

    Google Scholar 

  36. Gotoda T., Yamada N., Murase T., Sakuma M., Murayama N., Shimano H., Kozaki K., Albers J., Yazaki Y. and Adanuma Y. Differential phenotypic expression by three mutant alleles in familial LCAT deficiency. Lancet, 338, 1991, 778–781.

    Article  PubMed  CAS  Google Scholar 

  37. Maeda E., Naka Y., Matozaki T., Sakuma M., Akanuma Y., Yoshino G. and Kasuga M. LCAT deficiency with a missense mutation in exon 6 of the LCAT gene. B.B.R.C., 178, 1991, 460–466.

    CAS  Google Scholar 

  38. Skretting G., BlomhoffJ.P., Solheim J. and Prydz H. The genetic defect of the original Norwelfian lecithin: cholesterol and transferase deficiency families. F.E.B.S., 309, 1992, 307–310.

    CAS  Google Scholar 

  39. deficiency. J. Clin. Invest., 91, 1993, 677–683.

    Article  Google Scholar 

  40. and LCAT (TYR 156 As N). J.Lipid Res., 34, 1993, 49–58.

    Google Scholar 

  41. Dumon M.F., Berard A., Dabadie H., Rougier M.B. and Clerc M. Observation biochimique d’un nouveau cas de déficit classique en lécithine: cholesterol acyltransférase. Ann. Biol. Clin. (submitted).

    Google Scholar 

  42. Frolich J., Hoag G., Mc Leod R., Hayden M., Godin D.V., Wadsworth L.D. Critchley J.D., Pritchard P.H. Hypoalphalipoproteinemia resembling Fish Eye Disease. Acat Med. Scand., 221, 1987, 297–298.

    Google Scholar 

  43. Funke H., Von Eckardstein A., Pritchard P.H., Albers J.J., Kastelein J.J.P., Drost C. and Assmann G. A molecular defect causing Fish Eye Disease: an amino acid exchange in LCAT leads to the selective loss of alpha-LCAT activity. Proc. Natl. Acad. Sci. USA, 88, 1991, 4855–4859.

    Article  PubMed  CAS  Google Scholar 

  44. Klein H.G., Lohse P., Pritchard P.H., Bojanovski D., Schmidt H. and Brewer H.B. Two different allelic mutations in the LCAT gene associated with the Fish Eye syndrome. J. Clin. Invest., 89, 1992, 499–506.

    Article  CAS  Google Scholar 

  45. Skretting G. and Prydz H. An amino acid exchange in exon I of the human LCAT gene is associated with Fish Eye Disease. B.B.R.C., 182, 1992, 583–587.

    CAS  Google Scholar 

  46. Clerc M., Dumon M.F., Sess D., Freneix-Clerc M., Mackness M. and Conri C. A “Fish-Eye disease” familial condition with massive corneal opacities and hypoalphalipoproteinemia: clinical, biochemical and genetic features. Europ. J. Clin. Invest., 21, 1991, 616–624.

    Article  PubMed  CAS  Google Scholar 

  47. Klein H.G., Fojo S.S., Duverger N., Clerc M., Dumon M.F., Albers J.J., Marcovina S. and Brewer H.B. Fish-Eye syndrome: a molecular defect in LCAT gene associated with normal alpha-LCAT specific activity. Implications for classification and diagnosis. J. Clin. Invest., 92, 1993, 379–485.

    Google Scholar 

  48. Rader D.J., Ikewaki K., Duverger N., Schmidt H., Pritchard H., Frolich J., Clerc M., Dumon M.F., Fairwell T., Loren Z., Fojo S.S. and Brewer H.B. Rapid catabolism of apolipoprotein A-II and high density lipoproteins containing apo A-II in classic LCAT deficiency and Fish-Eye disease. J. Clin. Invest. (in press).

    Google Scholar 

  49. Kastelein J.J.P., Pritchard P.H., Erkelens D.W., Kuivenhoven J.A., Albers J.J. and Frolich J.J. Familial high density lipoprotein deficiency causing corneal opacities (Fish Eye disease) in a familial dutch descent. J. Intern. Med., 231, 1992, 413–419.

    Article  PubMed  CAS  Google Scholar 

  50. Assmann G., Schmitz G. and Brewer H.B. Familial high density lipoprotein deficiency: Tangier disease. in: The metabolic basis of inherited disease. Scriver C.R., Beaudet A.L., Sly W.S. and Valle D. Ed. Mc Graw-Hill Inc, N.Y., 1989, 11671282.

    Google Scholar 

  51. Dumon M.F., Freneix-Clerc M., Maviel M.J. and Clerc M. Familial hypocholesterolemia and HDL deficiency. Adv. Exp. Med., 285, 1991, 161–171.

    Article  CAS  Google Scholar 

  52. Norum R.A., Lakier J.B., Goldstein S., Angel A., Goldberg R.B., Block W.D., Nofze D., Dolphin P.J., Edelglass J., Bogorad DD and Alaupovic P. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N. Engi. J. Med., 306, 1982, 1513–1519.

    Article  CAS  Google Scholar 

  53. Oraovas J.M., Cassidy D.K., Civeira F., Bisgaier C.L. and Schaeffer E.J. Familial apo A-I, C-III and A-IV deficiency and premature atherosclerosis due to a deletion of a gene complex on chromosome il. J. Bio!. Chem., 264, 1989, 16339–16342.

    Google Scholar 

  54. Funke H.A., Von Eckardstein A., Pritchard P.H., Karas M., Albers J.J. and Assmann G. A frameshift mutation in the apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol acyltransferase deficiency and corneal opacities. J. Clin. Invest., 87, 1991, 371–376.

    Article  PubMed  CAS  Google Scholar 

  55. Schmitz G. and Williamson E. High-density lipoprotein metabolism, reverse cholesterol transport and membrane protection. Curr. Opin. Lipidol., 2, 1991, 177–189.

    Article  CAS  Google Scholar 

  56. Neary R., Bhatnagar D., Durrington P., Ishola M., Arroi S. and Mackness M. An investigation of the role of LCAT and triglyceride-rich lipoprotein in the metabolism of pre-beta high density lipoproteins. Atherosclerosis, 89, 1991 35–48.

    Article  PubMed  CAS  Google Scholar 

  57. Mackness M.I., Walker C.H. and Carlson L.A. Low A-Esterase activity in serum of patients with Fish-Eye disease. Clin. Chem., 33, 1987, 587–588.

    PubMed  CAS  Google Scholar 

  58. Mackness M.I., Peuchant E., Dumon M.F., Walker C.H. and Clerc M. Absence of “A”-Esterase activity in the serum of a patient with Tangier disease. Clin. Biochem., 22, 1989, 475–478.

    Article  PubMed  CAS  Google Scholar 

  59. Albers J.J., Bergelin R.O. and Aldolphson J.C. Population-based reference values for LCAT. Atherosclerosis, 43, 1982, 369–379.

    Article  PubMed  CAS  Google Scholar 

  60. Stokke K.T. and Norum K.R. Determination of LCAT in human blood plasma. Scand. J. Clin. Lab. Invest., 27, 1971, 21–27.

    Article  CAS  Google Scholar 

  61. Channon K.M., Clegg R.J., Bathnagar D., Ishola M., Arroi S. and Durrington P.N. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis, 80, 1990, 217–226.

    Article  PubMed  CAS  Google Scholar 

  62. Frohlich J. and Mc Leod R. LCAT deficiency syndromes. Adv. Exp. Med. Biol., 201, 1987, 181–194.

    Google Scholar 

  63. Barchiesi B.J., Eckel R.H. and Ellis P.P. The cornea and disorders of lipid metabolism. Survey. Ophtalm., 36, 1991, 1–22.

    Article  CAS  Google Scholar 

  64. Koster H., Savoldelli M., Dumon M.F., Dubourg L., Clerc M. and Pouliquen Y.J.M. A Fish-Eye disease like familial condition with massive corneal clouding and dyslipoproteinemia. Report of clinical, histologic, electron microscopic and biochemical features. Cornea, 11, 1992, 452–464.

    Article  PubMed  CAS  Google Scholar 

  65. Clerc M. and Pouliquen Y.J.M. L’Arcus juvenilis et les fonctions de la lecithin: cholesterol acyltransferase. A propos d’un cas familial de Fish-Eye disease. Bull. Acad. Nati. Med. Paris, 1993 (in press).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire Central de Biochimie, Hôpital Saint-Andre, 1, Rue Jean-Burguet, 33075, Bordeaux Cedex, France

    M. F. Dumon, A. Berard & M. Clerc

Authors
  1. M. F. Dumon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Berard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Clerc
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Manchester, Manchester, UK

    M. I. Mackness

  2. University of Bordeaux II, Bordeaux, France

    M. Clerc

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dumon, M.F., Berard, A., Clerc, M. (1994). LCAT: From Structure to Clinical Significance. In: Mackness, M.I., Clerc, M. (eds) Esterases, Lipases, and Phospholipases. NATO ASI Series, vol 266. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0993-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0993-0_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0995-4

  • Online ISBN: 978-1-4899-0993-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation